Search

everythinglearnresearchcommunity

for

Search:↓

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Spermidine helps protect against aging by preserving telomere length.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Stem-cell therapy shows promise for skin conditions but needs more research.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Patients with Shwachman-Diamond syndrome often get misdiagnosed due to a wide range of symptoms, including immune system problems and bone abnormalities.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.